Choosing Immune Suppression in Kidney Transplantation for Better Long-Term Graft Health
Official title: Choosing Immune Suppression in Renal Transplantation by Efficacy and Morbidity 2 (CISTEM2)
Funded at Rutgers Biomedical and Health Sciences · NIH-11416281 · Data updated 2026-11-12
A patient-friendly look at a study aimed at optimizing immune-suppressing medicines after kidney transplant to improve graft survival and reduce complications.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project start | February 1, 2025 |
| Project end | January 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $644,764 |
| NIH project number | 5R01DK139339-03 |
| Project ID | NIH-11416281 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults who have undergone kidney transplantation and are navigating long-term immune-suppressant therapy.
✕Less likely to help
Patients not yet receiving kidney transplants or those not involved in post-transplant care may not directly benefit.
What this research studies
This project uses large health data from kidney transplant patients to create a richer, more actionable picture of how different immune-suppressing medicines affect long-term graft health and safety. It builds on past work and adds more detailed clinical information and lab results to support better, shared decision-making between patients and clinicians. Researchers will link national transplant data with medical records and pharmacy information to study long-term outcomes like infections, cancer, diabetes, rejection, and survival. A patient-facing web tool will help providers and patients choose regimens that balance effectiveness with risks. The goal is to improve personalized care and outcomes for people living with kidney transplants.
Why it matters
Potential benefit: If successful, patients could benefit from more tailored immune-suppressant choices that improve graft longevity and reduce serious complications.
How similar studies have gone: Building on prior CISTEM work, this project aims to enhance evidence and tools for decision-making, with a track record suggesting meaningful progress is possible.
Where this research is happening
-
Rutgers Biomedical and Health Sciences
Newark, United States Active
Researchers
- Principal investigator: Dharnidharka, Vikas R. — Rutgers Biomedical and Health Sciences
- Study coordinator: Dharnidharka, Vikas R.
Related research
Other NIH-funded projects on the same topics.
-
Understanding how antibodies are produced after kidney transplants
This study is looking at how certain immune cells in the body create antibodies that can cause kidney transplants to be rejected, especially after the kidneys have been stored in cold conditions, and it aims to find ways to help improve transplant success for patients.
-
Identifying biomarkers to improve kidney transplant outcomes in children and young adults
This study is looking for ways to help kids and young adults who have had kidney transplants live longer and healthier by finding special signs that can predict how well their transplant will work.
-
Pilates exercises to improve balance, fatigue, and quality of life after kidney transplant
This study tests whether adding Pilates to standard physical therapy helps people aged 20–50 after a kidney transplant feel steadier, less fatigued, and have a better quality of life.
-
Transversalis fascia plane block to reduce pain after kidney transplant
See if a transversalis fascia plane block can reduce pain and opioid use after kidney transplant for adults aged 18–65 with ASA III.
-
Preoperative sensory modulation room to reduce pain, anxiety, and improve sleep for living kidney donors and recipients
The team will try a short preoperative session in a sensory modulation room to see if it lowers postoperative pain, reduces anxiety, and improves sleep for adult living kidney donors and transplant recipients.
-
Emotion-focused therapy to improve emotion regulation and well-being after kidney transplant
This project will try an emotion-focused therapy to see if it helps adults who have had a kidney transplant manage their emotions and feel better.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.